TIAM2
DGX icon

Tru Independence Asset Management 2’s Quest Diagnostics DGX Stock Holding History

Tru Independence Asset Management 2’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,146
Closed -$404K – 114
2021
Q1 		$404K Sell
3,146
-21
-0.7% -$2.59K 0.32% 71
2020
Q4 		$377K Buy
+3,167
New +$386K 0.32% 69

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Tru Independence Asset Management 2's DGX Position: Q2 2021 in Review

Tru Independence Asset Management 2 sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 3,146 shares — an estimated $404K sold.

Tru Independence Asset Management 2 first reported a position in DGX in Q4 2020 and held it in 2 quarters. The position peaked at $404K in Q1 2021. 815 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

  • Tru Independence Asset Management 2 reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Tru Independence Asset Management 2 sold 3,146 Quest Diagnostics shares in Q2 2021, an estimated $404K.
  • Tru Independence Asset Management 2 first reported a position in Quest Diagnostics in Q4 2020 and held it in 2 quarters.
  • Tru Independence Asset Management 2's Quest Diagnostics position peaked at $404K in Q1 2021.
  • 815 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on Tru Independence Asset Management 2's 13F filing for Q2 2021, filed 21 Jul 2021.